Mostrar el registro sencillo del ítem

dc.contributor.authorTrujillo Rodríguez, María
dc.contributor.authorPraena Fernández, Juan Manuel 
dc.date.accessioned2023-05-22T09:05:17Z
dc.date.available2023-05-22T09:05:17Z
dc.date.issued2022-07-14
dc.identifier.citationTrujillo-Rodriguez M, Muñoz-Muela E, Serna-Gallego A, Praena-Ferna´ndez JM, Pe´rez- Go´mez A, Gasca-Capote C, et al. (2022) Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients. PLoS ONE 17(7): e0269875. [https://doi.org/10.1371/journal.pone.0269875]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/81702
dc.description.abstractBackground The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation. Methods Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic, laboratory data and plasma samples were collected at admission. The patients were classified into mild and severe/critical groups according to 4-point ordinal categories based on oxygen therapy requirements. Logistic regression models were performed in mild patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory cytokine levels to predict both early discharge and worsening. Results 333 patients were included. At admission, 307 patients were classified as mild patients. Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio (NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value (PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included, lower interferon-γ-inducible protein 10 and higher Interleukin 1 beta levels were associated with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%). The model to predict worsening included male sex, oxygen saturation, no corticosteroids treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903; SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and soluble IL-2Rα (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%). Conclusions Clinical and routine laboratory data at admission strongly predict non-worsening during the first two weeks; therefore, these variables could help identify those patients who do not need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory cytokines moderately improves these predictive capacities.es_ES
dc.description.sponsorshipConsejeria de Salud y Familia COVID-00052020 RH-0037-2020es_ES
dc.description.sponsorshipConsejeria de Transformacion Economica, Industria, Conocimiento y Universidades PY20/01276es_ES
dc.description.sponsorshipInstituto de Salud Carlos III CP19/00159 CP19/00146 FI19/00304 FI19/00083 COV20/00698es_ES
dc.description.sponsorshipRed Tematica de Investigacion Cooperativa en SIDA RD16/0025/0020 RD16/0025/0006 RD16/0025/0026es_ES
dc.description.sponsorshipEuropean Commissiones_ES
dc.description.sponsorshipCentro de Investigacion Biomedica en Red de Enfermedades Infecciosas-ISCIII Madrid, Spain CB21/13/00020es_ES
dc.description.sponsorshipSpanish Research Council (CSIC)es_ES
dc.description.sponsorshipIISPV 2019/IISPV/05es_ES
dc.description.sponsorshipGeSIDAes_ES
dc.language.isoenges_ES
dc.publisherPloses_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleClinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientses_ES
dc.title.alternativeClinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1371/journal.pone.0269875
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]
[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional